Removal of endocrine disruptors and pharmaceuticals during water treatment

Fate of Pharmaceuticals in the Environment and in Water Treatment Systems

Volumn , Issue , 2007, Pages 229-260

  Snyder, Shane A ^a   Lei, Hongxia ^a   Wert, Eric C ^a  

^a SOUTHERN NEVADA WATER AUTHORITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84905591306     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420052336     Document Type: Chapter

References (75)

1. Stumm-Zollinger, E. and Fair, G.M., Biodegradation of steroid hormones. J. Water Poll. Contr. Fed. 1965, 37, 1506-1510.
2. Tabak, H.H. and Bunch, R.L., Steroid hormones as water pollutants. I. Metabolism of natural and synthetic ovulation-inhibiting hormones by microorganisms of activated sludge and primary settled sewage. Dev. Ind. Microbiol. 1970, 11, 367-376.
3. Schueler, F.W., Sex-hormonal action and chemical constitution. Science 1946, 103, 221-223.
4. Sluczewski, A. and Roth, P., Effects of androgenic and estrogenic compounds on the experimental metamorphoses of amphibians. Gynecol. and Obstet. 1948, 47, 164-176.
5. Hignite, C. and Azarnoff, D.L., Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicylic acid in sewage water effluent. Life Sci. 1977, 20, 337-341.
6. Purdom, C.E., Hardiman, P.A., Bye, V.J., Eno, N.C., Tyler, C.R., and Sumpter, J.P., Estrogenic effects of effluents from sewage treatment works. Chem. Ecol. 1994, 8, 275-285.
7. Desbrow, C., Routledge, E.J., Brighty, G.C., Sumpter, J.P., and Waldock, M., Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environ. Sci. Technol. 1998, 32, 1549-1558.
8. Routledge, E.J., Sheahan, D., Desbrow, C., Brighty, G.C., Waldock, M., and Sumpter, J.P., Identification of estrogenic chemicals in STW effluent. 2. In vivo responses in trout and roach. Environ. Toxicol. Chem. 1998, 32, 1559-1565.
9. Halling-Sorensen, B., Nielsen, S.N., Lanzky, P.F., Ingerslev, F., Lutzhoft, H.C.H., and Jorgensen, S.E., Occurrence, fate and effects of pharmaceutical substances in the environment— A review. Chemosphere 1998, 36, 357-393.
10. Ternes, T.A., Hirsch, R., Mueller, J., and Haberer, K., Methods for the determination of neutral drugs as well as betablockers and β2-sympathomimetics in aqueous matrices using GC/MS and LC/MS/MS. Fresenius’ J. Anal. Chem. 1998, 362, 329-340.
11. Daughton, C.G. and Ternes, T.A., Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ. Health Perspectives 1999, 107, 907-938.
12. Snyder, S.A., Keith, T.L., Verbrugge, D.A., Snyder, E.M., Gross, T.S., Kannan, K., and Giesy, J.P., Analytical methods for detection of selected estrogenic compounds in aqueous mixtures. Environ. Sci. Technol. 1999, 33, 2814-2820.
13. Metcalfe, C.D., Koenig, B., Ternes, T.A., and Hirsch, R., Drugs in sewage treatment plant effluents in Canada. In Proceedings for ACS National Meeting, 2000, vol 40, 100-102.
14. Ternes, T.A. and Hirsch, R., Occurrence and behavior of x-ray contrast media in sewage facilities and the aquatic environment. Environ. Sci. Technol. 2000, 34, 2741-2748.
15. Snyder, S.A., Kelly, K.L., Grange, A.H., Sovocool, G.W., Snyder, E.M., and Giesy, J.P., Pharmaceuticals and personal care products in the waters of Lake Mead, Nevada. In Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues, Daughton, C.G.; Jones-Lepp, T.L., Eds., American Chemical Society: Washington, D.C., 2001; Symposium Series 791, pp 116-140.
16. Kolpin, D.W., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B., and Buxton, H.T., Pharmaceuticals, hormones, and other organic waste contaminants in U.S. Streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 2002, 36, 1202-1211.
17. Vanderford, B.J., Pearson, R.A., Rexing, D.J., and Snyder, S.A., Analysis of endocrine disruptors, pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry. Anal. Chem. 2003, 75, 6265-6274.
18. Cargouet, M., Perdiz, D., Mouatassim-Souali, A., Tamisier-Karolak, S., and Levi, Y., Assessment of river contamination by estrogenic compounds in Paris area (France). Sci. Tot. Environ. 2004, 324, 55-66.
19. Petrovic, M., Eljarrat, E., Lopez de Alda, M.J., and Barcelo, D., Endocrine disrupting compounds and other emerging contaminants in the environment: a survey on new monitoring strategies and occurrence data. Anal. Bioanal. Chem. 2004, 378, 549-562.
20. Ternes, T.A., Kreckel, P., and Mueller, J., Behavior and occurrence of estrogens in municipal sewage treatment plants—II. Aerobic batch experiments with activated sludge. Sci. Total Environ. 1999, 225, 91-99.
21. Ternes, T.A., Stumpf, M., Mueller, J., Haberer, K., Wilken, R.D., and Servos, M., Behavior and occurrence of estrogens in municipal sewage treatment plants—I. Investigations in Germany, Canada and Brazil. Sci. Total Environ. 1999, 225, 81-90.
22. D’Ascenzo, G., Di Corcia, A., Gentili, A., Mancini, R., Mastropasqua, R., Nazzari, M., and Samperi, R., Fate of natural estrogen conjugates in municipal sewage transport and treatment facilities. Sci. Total Environ. 2003, 302, 199-209.
23. Huber, M.M., Korhonen, S., Ternes, T.A., and von Gunten, U., Oxidation of pharmaceuticals during water treatment with chlorine dioxide. Water Res. 2005, 39, 3607-3617.
24. Zwiener, C. and Frimmel, F.H., Oxidative treatment of pharmaceuticals in water. Water Res. 2000, 34, 1881-1885.
25. Adams, C., Wang, Y., Loftin, K., and Meyer, M., Removal of antibiotics from surface and distilled water in conventional water treatment processes. J. Environ. Eng.—ASCE 2002, 128, 253-260.
26. Drewes, J.E., Heberer, T., and Reddersen, K., Fate of pharmaceuticals during indirect potable reuse. Water Sci. Technol. 2002, 46, 73-80.
27. Snyder, S.A., Westerhoff, P., Yoon, Y., and Sedlak, D.L., Pharmaceuticals, personal care products, and endocrine disruptors in water: Implications for the water industry. Environ. Sci. Technol. 2003, 20, 449-469.
28. Huber, M.M., Göbel, A., Joss, A., Hermann, N., Löffler, D., McArdell, C.S., Reid, A., Siegrist, H., Ternes, T.A., and von Gunten, U., Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ. Sci. Technol. 2005, 39, 4290-4299.
29. Yoon, Y., Westerhoff, P., Snyder, S.A., Wert, E.C., and Yoon, J., Removal of endocrine disrupting compounds and pharmaceuticals by nanofiltration and ultrafiltration membranes. Desalination 2006, 202, 16-23.
30. Snyder, S.A., Wert, E.C., Rexing, D.J., Zegers, R.E., and Drury, D.D., Ozone oxidation of endocrine disruptors and pharmaceuticals in surface water and wastewater. Ozone-Sci. Eng. 2006, 28, 445-460.
31. Snyder, S.A., Adham, S., Redding, A.M., Cannon, F.S., DeCarolis, J., Oppenheimer, J., Wert, E.C., and Yoon, Y., Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 2006, 202, 156-181.
32. Ternes, T.A., Meisenheimer, M., Mcdowell, D., Sacher, F., Brauch, H.-J., Haist-Gulde, B., Preuss, G., Wilme, U., and Zulei-Seibert, N., Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 2002, 36, 3855-3863.
33. Westerhoff, P., Yoon, Y., Snyder, S., and Wert, E., Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 2005, 39, 6649-6663.
34. Tixier, C., Singer, H.P., Oellers, S., and Mueller, S.R., Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ. Sci. Technol. 2003, 37, 1061-1068.
35. Loraine, G.A. and Pettigrove, M.E., Seasonal variations in concentrations of pharmaceuticals and personal care products in drinking water and reclaimed wastewater in southern California. Environ. Sci. Technol. 2006, 40, 687-695.
36. Vieno, N.M., Tuhkanen, T., and Kronberg, L., Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ. Sci. Technol. 2005, 39, 8220-8226.
37. Vieno, N., Tuhkanen, T., and Kronberg, L., Removal of pharmaceuticals in drinking water treatment: effect of chemical coagulation. Environ. Tech. 2006, 27, 183-192.
38. Stackelberg, P.E., Furlong, E.T., Meyer, M.T., Zaugg, S.D., Henderson, A.K., and Reissman, D.B., Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci. Total Environ. 2004, 329, 99-113.
39. Zuccato, E., Castiglioni, S., Fanelli, R., Reitano, G., Bagnati, R., Chiabrando, C., Pomati, F., Rossetti, C., and Calamari, D., Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control. Environ. Sci. Pollut. R. 2006, 13, 15-21.
40. Castiglioni, S., Bagnati, R., Fanelli, R., Pomati, F., Calamari, D., and Zuccato, E., Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol. 2006, 40, 357-363.
41. Zuehlke, S., Duennbier, U., and Heberer, T., Determination of polar drug residues in sewage and surface water applying liquid chromatography-tandem mass spectrometry. Anal. Chem. 2004, 76, 6548-6554.
42. Moldovan, Z., Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania. Chemosphere 2006, 64, 1808-1817.
43. Yasojima, M., Nakada, N., Komori, K., Suzuki, Y., and Tanaka, H., Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan. Water Sci. Technol. 2006, 53, 227-233.
44. Nakada, N., Yasojima, M., Okayasu, Y., Komori, K., Tanaka, H., and Suzuki, Y., Fate of oestrogenic compounds and identification of oestrogenicity in a wastewater treatment process. Water Sci. Technol. 2006, 53, 51-63.
45. Kolpin, D.W., Skopec, M., Meyer, M.T., Furlong, E.T., and Zaugg, S.D., Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions. Sci. Total Environ. 2004, 328, 119-130.
46. Hunt, J.W., Anderson, B.S., Phillips, B.M., Tjeerdema, R.S., Puckett, H.M., and deVlaming, V., Patterns of aquatic toxicity in an agriculturally dominated coastal watershed in California. Agr. Ecosyst. Environ. 1999, 75, 75-91.
47. Schwarzbauer, J., Heim, S., Brinker, S., and Littke, R., Occurrence and alteration of organic contaminants in seepage and leakage water from a waste deposit landfill. Water Res. 2002, 36, 2275-2287.
48. Turnidge, J., Antibiotic use in animals-prejudices, perceptions and realities. J. Antimicrob. Chemoth. 2004, 53, 26-27.
49. Trenholm, R.A., Vanderford, B.J., Holady, J.C., Rexing, D.J., and Snyder, S.A., Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectroscopy. Chemosphere 2006, 65, 1990-1998.
50. Carballa, M., Omil, F., and Lema, J.M., Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment. Water Res. 2005, 39, 4790-4796.
51. Jones, O.A.H., Voulvoulis, N., and Lester, J.N., Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res. 2002, 36, 5013-5022.
52. Qiu, H.C., Jun, H.W., and McCall, J.W., Pharmacokinetics, formulation, and safety of insect repellent N, N-diethyl-3-methylbenzamide (DEET): a review. J. Am. Mosquito Contr. 1998, 14, 12-27.
53. Deborde, M., Rabouan, S., Duguet, J.-P., and Legube, B., Kinetics of aqueous ozoneinduced oxidation of some endocrine disruptors. Environ. Sci. Technol. 2005, 39, 6086-6092.
54. Huber, M.M., Canonica, S., Park, G.-Y., and von Gunten, U., Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 2003, 37, 1016-1024.
55. Noaksson, E., Gustavsson, B., Linderoth, M., Zebuhr, Y., Broman, D., and Balk, L., Gonad development and plasma steroid profiles by HRGC/HRMS during one reproductive cycle in reference and leachate-exposed female perch (Perca fluviatilis). Toxicol. Appl. Pharm. 2004, 195, 247-261.
56. EC, Risk assessment musk ketone. European Union Risk Assessment Report. Final Draft, June 2003.
57. Simonich, S.L., Begley, W.M., Debaere, G., and Eckhoff, W.S., Trace analysis of fragrance materials in wastewater and treated wastewater. Environ. Sci. Technol. 2000, 34, 959-965.
58. Dodd, M.C., Buffle, M.O., and von Gunten, U., Oxidation of antibacterial molecules by aqueous ozone: Moiety-specific reaction kinetics and application to ozone-based wastewater treatment. Environ. Sci. Technol. 2006, 40, 1969-1977.
59. Loftsson, T. and Hreinsdottir, D., Determination of aqueous solubility by heating and equilibration: a technical note. AAPS Pharm. Sci. Tech. 2006, 7, E1-E4.
60. Snyder, S.A., Wert, E.C., Edwards, J., Budd, G., Long, B., and Rexing, D., Magnetic ion exchange (MIEX) for the removal of endocrine disrupting chemicals and pharmaceuticals. In Proceedings of Water Quality and Technology Conference, AWWA: San Antonia, TX, 2004.
61. Crittenden, J.C., Sanongraj, S., Bulloch, J.L., Hand, D.W., Rogers, T.N., Speth, T.F., and Ulmer, M., Correlation of aqueous-phase adsorption isotherms. Environ. Sci. Technol. 1999, 33, 2926-2933.
62. Na, C., Cannon, F.S., and Hagerup, B., Perchlorate removal via iron-reloaded GAC and borohydride regeneration. J. Am. Water Works Assoc. 2002, 94, 90-102.
63. Bolton, J.R., and Linden, K.G., Standardization of methods for fluence (UV dose) determination in bench-scale experiments. J. Environ. Eng.—ASCE 2003, 129, 209-216.
64. Rosenfeldt, E. and Linden, K.G., Degradation of endocrine disrupting chemicals bisphenol A, ethinyl estradiol, and estradiol during UV photolysis and advanced oxidation processes. Environ. Sci. Technol. 2004, 38, 5476-5483.
65. Deborde, M., Rabouan, S., Gallad, H., and Legube, B., Aqueous chlorination kinetics of some endocrine disruptors. Environ. Sci. Technol. 2004, 38, 5577-5583.
66. Lee, B.-C., Kamata, M., Akatsuka, Y., Takeda, M., Ohno, K., Kamei, T., and Magara, Y., Effects of chlorine on the decrease of estrogenic chemicals. Water Res. 2004, 38, 733-739.
67. Faust, S.D. and Hunter, J.V., Principles and Applications of Water Chemistry. John Wiley and Sons: New York, 1967.
68. Gallard, H. and von Gunten, U., Chlorination of phenols: Kinetics and formation of chloroform. Environ. Sci. Technol. 2002, 36, 884-890.
69. Snyder, S.A., Leising, J., Westerhoff, P., Yoon, Y., Mash, H., and Vanderford, B.J., Biological attenuation of EDCs and PPCPs: Implications for water reuse. Ground Water Monit. R. 2004, 24, 108-118.
70. Li, Q.L., Snoeyink, V.L., Marinas, B.J., and Campos, C., Pore blockage effect of NOM on atrazine adsorption kinetics of PAC: the roles of PAC pore size distribution and NOM molecular weight. Water Res. 2003, 37, 4863-4872.
71. Knappe, D.R.U., Matsui, Y., Snoeyink, V.L., Roche, P., Prados, M.J., and Bourbigot, M.-M., Predicting the capacity of powder activated carbon for trace organic compounds in natural waters. Environ. Sci. Tech. 1998, 32, 1694-1698.
72. Zhang, Y. and Zhou, J.L., Removal of estrone and 17β-estradiol from water by adsorption. Water Res. 2005, 39, 3991-4003.
73. Westerhoff, P., Debroux, J., Aiken, G., and Amy, G., Ozone-induced changes in natural organic matter (NOM) structure. Ozone-Sci. Eng. 1999, 21, 551-570.
74. Bose, P., Bezbarua, B.K., and Reckhow, D.A., Effect of ozonation on some physical and chemical properties of aquatic natural organic-matter. Ozone-Sci. Eng. 1994, 16, 89-112.
75. Vuorio, E., Vahala, R., Rintala, J., and Laukkanen, R., The evaluation of drinking water treatment performed with HPSEC. Environ. Int. 1998, 24, 617-623.